SCHEMBL5575642

SCHEMBL5575642

CCCCCCCCCCCCCCCCCCCCCCCCCCN=C=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.58
TSHR P16473 5/20 0.42
THRB P10828 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CES2 O00748 3/20 0.35
CES1 P23141 3/20 0.35
EPHX2 P34913 1/20 0.35
GSK3B P49841 1/20 0.34
ALDH1A1 P00352 3/20 0.33
PPARG P37231 3/20 0.33
PPARD Q03181 3/20 0.33
PPARA Q07869 3/20 0.33
GPR84 Q9NQS5 2/20 0.33
DNM1 Q05193 2/20 0.33
HDAC11 Q96DB2 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
HSD17B10 Q99714 2/20 0.33
SLC22A6 Q4U2R8 1/20 0.33
SLC22A8 Q8TCC7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hexane SCHEMBL2866709 1.00 NAAA (0.58) NAAATSHRTHRBMEN1KMT2A
SCHEMBL10870593 1.00 NAAA (0.58) NAAATSHRTHRBMEN1KMT2A
SCHEMBL5571386 1.00 NAAA (0.58) NAAATSHRTHRBMEN1KMT2A
SCHEMBL37419 1.00 NAAA (0.58) NAAATSHRTHRBMEN1KMT2A
SCHEMBL10791564 1.00 NAAA (0.58) NAAATSHRTHRBMEN1KMT2A
Nonane SCHEMBL3071312 1.00 NAAA (0.58) NAAATSHRTHRBMEN1KMT2A
SCHEMBL1493031 1.00 NAAA (0.58) NAAATSHRTHRBMEN1KMT2A
SCHEMBL15486455 1.00 NAAA (0.58) NAAATSHRTHRBMEN1KMT2A
SCHEMBL527174 1.00 NAAA (0.58) NAAATSHRTHRBMEN1KMT2A
SCHEMBL27220 1.00 NAAA (0.58) NAAATSHRTHRBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3728376-A1 SOFTENING COMPOSITION Coatex (FR) 2020-10-28 EP claimed
CN-115667599-B Heat storage composition 住友化学株式会社 2026-05-12 CN disclosed
US-12378367-B2 Aqueous thickening composition COATEX (FR) 2025-08-05 US disclosed
EP-4588979-A2 POLYMER, MOLDED BODY, FOAM, RESIN COMPOSITION, AND PRODUCTION METHOD FOR POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2025-07-23 EP disclosed
WO-2025126887-A1 ARTICLE HAVING HEAT STORAGE PERFORMANCE 住友化学株式会社 2025-06-19 WO disclosed
EP-3473653-B1 POLYMER, MOLDED BODY, FOAM, RESIN COMPOSITION, AND PRODUCTION METHOD FOR POLYMER SUMITOMO CHEMICAL CO (JP) 2025-06-11 EP disclosed
EP-3492526-B1 RESIN COMPOSITION AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2025-02-19 EP disclosed
EP-3473678-B1 RESIN COMPOSITION AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2025-01-01 EP disclosed
EP-4342958-A1 HEAT STORAGE COMPOSITION Sumitomo Chemical Company Limited (JP) 2024-03-27 EP disclosed
CN-117321172-A Heat storage composition 住友化学株式会社 2023-12-29 CN disclosed
US-20190143639-A1 LAMINATE, BUILDING MATERIAL, BUILDING, AND HEAT INSULATING CONTAINER SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2019-05-16 US disclosed
US-20190144676-A1 POLYMER, MOLDED BODY, FOAM, RESIN COMPOSITION, AND PRODUCTION METHOD FOR POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-05-16 US disclosed
EP-3473678-A1 RESIN COMPOSITION AND USE THEREOF Sumitomo Chemical Company Limited (JP) 2019-04-24 EP disclosed
EP-3473432-A1 LAMINATE, BUILDING MATERIAL, BUILDING, AND HEAT INSULATING CONTAINER Sumitomo Chemical Company Limited (JP) 2019-04-24 EP disclosed
EP-3473653-A1 POLYMER, MOLDED BODY, FOAM, RESIN COMPOSITION, AND PRODUCTION METHOD FOR POLYMER Sumitomo Chemical Company Limited (JP) 2019-04-24 EP disclosed
US-20180360029-A1 RESIN PRODUCT AND MEDICINAL COMPONENT DISPENSING DEVICE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-12-20 US disclosed
EP-3385332-A1 RESIN PRODUCT AND MEDICINAL COMPONENT DISPENSING DEVICE Sumitomo Chemical Company, Limited (JP) 2018-10-10 EP disclosed
US-20180030175-A1 POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-02-01 US disclosed
EP-3235836-A1 POLYMER Sumitomo Chemical Company, Ltd. (JP) 2017-10-25 EP disclosed
WO-2007019478-A2 DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS - THERAPEUTIC SAMS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180360029-A1 RESIN PRODUCT AND MEDICINAL COMPONENT DISPENSING DEVICE SAMM50, EXOSC9, ATP5ME NAAA 2814/4885TSHR 4393/4885THRB 3980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.